Protective effect of L carnitine against diclofenac sodium toxicity in mice

Revue de Medecine Veterinaire

Volumn 159, Issue 6, 2008, Pages 363-367

  Yapar, K ^a   Atakisi, O ^a   Uzlu, E ^a   Citil, M ^a   Uzun, M ^a   Metin Erdogan, H ^a  

^a KAFKAS UNIVERSITY   (Turkey)

Author keywords

Diclofenac sodium; Glutathione; Kidney; Lipid peroxidation; Liver; Markers; Toxicity

Indexed keywords

MUS;

EID: 48849113099     PISSN: 00351555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ANDRIEU-ABADIE N., JAFFREZOU J.P., HATEM S., LAURENT G., LEVADE T., MERCADIER J.J.: L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J., 1999, 13, 1501-1510.
2. ARDUINI A.: Carnitine and its acyl esters as secondary antioxidants? Am. Heart. J., 1992, 123, 1726-1727.
3. AROCKIA RANI P.J., PANNEERSELVAM C.: L-carnitine as a free radical scavenger in aging. Exp. Gerontol., 2001, 36, 1713-1726.
4. ARSLAN C.: L- Carnitine and its use a feed additive in poultry feeding a review. Rev. Med. Vet., 2006, 157, 134-142.
5. ATROSHI F., RIZZO A., BIESE L., VEIJALAINEN P., SALONIEMI H., SANKARI S., ANDERSSON K.: Fumosin B1-induced DNA damage in rat liver and spleen: Effect of pre-treatment with coenzyme Q10, L-carnitine, a-tocoferol and selenium. Pharm. Res., 1999, 40, 459-467.
6. AYDIN G., GOKCIMEN A., ONCU M., CICEK E., KARAHAN N., GOKALP O.: Histopathological changes in liver and renal tissues induced by different doses of diclofenac sodium rats. Turk. J. Vet. Anim. Sci., 2007, 27, 1131-1140.
7. BERGH M.S., BUDSBERG S.C.: The COXIB NSAIDS: Potential clinical and pharmacologic importance in veterinary medicine. J. Vet. Intern. Med., 2005, 19, 633-643.
8. BEUTLER E., DURAN O., KELLEY B.M.: Improved method for determination of blood glutathion. J. Lab. Clin. Med., 1963, 28, 882-888.
9. BHAGAT H., MALHOTRA K., TYAGI C., GANGWAR N., PAL N.: Evaluation of preoperative rectal diclofenac for peri-operative analgesia in ENT surgery, Indian. J. Anaesth., 2003, 47, 463-466.
10. BJORKMAN D.: Non steroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract and esophagus. Am. J. Med., 1998, 105, 17-21.
11. BORT R., PONSODA X., JOVER R., GOMEZ-LECHON M.J., CASTELL J.V.: Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. J. Pharmacol. Exp. Ther., 1999, 288, 65-72.
12. BRASS E.M.: Supplemental carnitine and exercise. Am. J. Clin. Nutr., 2000, 72, 618-623.
13. BUSH T.M., SHLOTZHAUER T.L., IMAI K.: Non steroidal anti-inflammatory drugs. Proposed guidelines for monitoring toxicity. West. J. Med., 1991, 155, 39-42.
14. CETIN M., PETEK M., POLAT U., YALCIN A.: Effects of dietary carnitine supplementation on plasma carnitine and some serum biochemical parameters in lambs. Rev. Med. Vet., 2003, 154, 195-198.
15. CLIVE D.M., STOFF J.S.: Renal syndromes associated with non-steroidal anti-inflammatory drugs. N. Engl. J. Med., 1984, 310, 563-572.
16. DEUFEL T.: Determination of L-carnitine in biological fluids and tissues. J. Clin. Chem. Clin. Biochem., 1990, 28, 307-311.
17. ERTEKIN A., SAHIN A., KARACA M., AKKAN H.A., BAKIR B.: The effect of dipyrone overdoses on the levels of lipid peroxidation, glutathione and ceruloplasmin in dogs. YYÜ. Vet. Fak. Derg., 2001, 12, 105-107.
18. HICKEY E.J., RAJE R.R., REID V.E., GROSS S.M., RAY S.D.: Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic. Biol. Med., 2001, 31, 139-152.
19. 2+ induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys., 1979, 195, 453-459.
20. th Edition, New York, USA, 1990.
21. KALAISELVI T., PANNEERSELVAM C.: Effect of L-carnitine on the status of lipid peroxidation and antioxidants in aging rats. J. Nutr. Biochem., 1998, 9, 575-581.
22. KART A., YAPAR K., KARAPEHLIVAN M., CITIL M.: The possible protective effects of L-carnitine on tilmicosin-induced cardiotoxicity in mice. J. Vet. Med. A., 2007, 54, 144-146.
23. KART A., YAPAR K., KARAPEHLIVAN M., TUNCA R., OGUN M., CITIL M.: Effects of L-carnitine on kidney histopathology, plasma and tissue total sialic acid, malondialdehyde and glutathione concentrations in response to gentamicin administration in Balb/C mice. Rev. Med. Vet., 2006, 157, 179-187.
24. KELLY G.S.: L-carnitine: Therapeutic applications of a conditionally-essential amino acid. Altern. Med. Rev., 1998, 3, 345-360.
25. MILLER L.G., BOWMAN R.C.: Selective effect of diclofenac in the treatment of osteoarthritis versus dysmenorrhea. J. Clin. Pharmacol., 1990, 30, 378-379.
26. MINGATTO F.E., SANTOR A.C., UYEMURA S.A.: In vitro interaction of non steroidal anti-inflammatory drugs on oxidative phosphorylation of rat. Arch. Biochem. Biophys., 1996, 334, 303-308.
27. O'CONNOR N., DARGAN P.J., JONES A.L.: Hepatocellular damage from non-steroidal anti-inflammatory drugs. Q. J. Med., 2003, 96, 787-791.
28. PALMER B.F.: Renal complications associated with use of non steroidal anti-inflammatory agents. J. Invest. Med., 1995, 43, 516-553.
29. SCHMITZ G., LEPPER H., ESTLER C.J.: Changes in energy homeostasis and GSH-depletion as possible mechanisms of diclofenac induced cytotoxicity on isolated rat hepatocytes. Arch. Pharmacol., 1995, 77, 32-35.
30. SENER G., PASKALOGLU K., SATIROGLU H., ALICAN I., KACMAZ A., SAKARCAN A.: L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. Cardiovasc. Pharmacol., 2004, 43, 698-705.
31. SERGIO A.U., ANTONIO C.S.: Diclofenac sodium and mefenamic acid: Potent inducers of the membrane permeability transition in renal cortex mitochondria. Arch. Biochem. Biophys., 1997, 342, 231-235.
32. SHENN C.L., MACDONALD T.M.: Gastrointestinal side effects of NSAIDs: pharmacoeconomic implications. Expert. Opin. Pharmacother., 2002, 3, 265-269.
33. SKOUTAKIS V.A., CARTER C.A., MICKLE T.R., SMITH V.H., ARKIN C.R., ALISSANFRATOS J., PETTY D.F.: Review of diclofenac and evaluation of its place in therapy as a non steroidal anti-inflammatory agent. Drug. Intelol. Clin. Pharm., 1988, 22, 850-859.
34. TAKAYAMA F., EGASHIRA T., YAMANAKA Y.: Effect of diclofenac, a non-steroidal anti-inflammatory drug, on lipid peroxidation caused by ischemia-reperfusion in rat liver. Jpn. J. Pharmacol., 1994, 64, 71-78.
35. WARNER T.D., MITCHELL J.A.: Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J., 2004, 18, 790-804.
36. WINKLER B.S.: Unequal evidence in support of the non-enzymatic redox coupling between glutathione / glutathione disulfide and ascorbic acid / dehydroascorbic acid. Biochem. Biophys. Acta., 1992, 1117, 287-290.
37. YOSHOIKO T., KAWADA K., SHIMADA T.: Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am. J. Obstet. Gynecol. 1979, 135, 372-376.